Gossamer Bio GOSS Cash Flow Statement (2018-2026)

NASDAQ GOSS
$0.16 -0.02 (-11.23%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Gossamer Bio Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Gossamer Bio reported cash from operations of -$39.42M and free cash flow of -$39.42M for the quarter ended Jun 2026, up 16.2% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-60.36M-56.36M-58.19M-57.05M-59.03M-57.22M-50.85M-42.50M-40.01M-48.15M-44.74M49.23M-30.80M-33.03M-39.26M-38.27M-48.22M-47.24M-47.27M-28.51M
Share-based CompensationStock Comp.
7.59M7.66M10.98M10.00M10.12M11.45M8.13M8.20M6.16M6.03M5.81M5.00M4.84M4.96M2.40M2.59M2.67M2.90M6.30M38.94M
Gains from Investment SecuritiesGains Investment
-1.60M
Cash from OperationsCash from Ops.
-42.03M-40.51M-53.48M-48.82M-37.00M-47.73M-52.99M-38.25M-34.49M-33.42M-52.30M116.35M-32.03M-35.48M-39.72M-47.06M-36.17M-48.31M-38.72M-39.42M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.86M0.83M0.65M0.64M0.65M0.66M1.53M1.50M2.83M3.58M3.05M2.99M3.66M3.36M2.67M1.94M1.58M1.08M0.66M0.39M
Amortization of Deferred ChargesAmort. Deferred Charges
0.01M1.75M0.29M0.01M0.01M0.27M0.35M0.01M0.01M0.31M0.29M0.01M0.01M0.24M0.24M0.01M0.02M0.25M0.26M0.02M
Depreciation & Amortization (CF)Dep. & Amort.
0.50M0.44M0.50M0.50M0.50M0.43M0.50M0.50M0.40M0.29M0.26M0.30M0.20M0.11M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
3.63M2.96M-1.25M1.25M1.00M1.66M2.98M-2.98M-3.15M
Change in Account PayablesChange Payables
-0.18M2.38M-2.51M3.71M-3.30M0.28M1.22M-0.51M-0.99M4.26M-2.92M-1.52M-0.29M3.08M-0.94M-5.84M-0.80M4.82M6.16M-4.59M
Change in Accured ExpensesChange Accured Exp.
8.97M-3.98M-5.80M2.62M5.67M-4.14M-8.12M2.78M0.85M1.24M-9.27M2.99M-3.50M-0.94M-5.84M3.01M5.33M-1.05M2.50M-4.65M
Other Working Capital ChangesOther WC Changes
66.70M-2.59M-8.19M-1.38M0.43M-3.91M-1.46M-8.95M-3.42M
Investing Activities
Capital ExpendituresCapex
0.52M0.08M0.16M0.12M0.03M0.10M0.03M0.05M
Change in Acquisitions & DivestmentsChange Acquisitions
4.75M18.68M46.00M40.00M65.50M86.00M85.60M69.40M69.80M105.90M147.80M134.50M104.60M136.90M123.10M119.70M46.60M87.00M66.60M42.70M
Cash from Investing ActivitiesCash from Investing
-89.76M10.44M8.42M4.68M-22.60M8.46M8.72M12.94M-118.26M-14.37M61.67M-59.11M-26.75M53.22M22.06M44.13M17.01M73.16M41.61M42.70M
Financing Activities
Other financing activitiesOther financing
0.88M0.37M0.59M119.33M0.02M0.37M200.96M0.35M0.28M0.37M0.57M2.72M0.29M
Cash from Financing ActivitiesCash from Financing
1.91M0.37M0.72M0.02M119.22M-2.87M-2.54M-2.90M198.50M-2.90M-2.56M-9.21M0.28M0.50M0.09M1.87M3.96M0.51M-3.14M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.59M
Additional items
Exchange Rate EffectFX Effect
0.40M-0.38M-0.15M-0.53M-0.47M0.64M0.07M-0.02M-0.14M0.19M-0.06M-0.01M0.09M-0.12M0.10M0.13M-0.10M0.00M-0.10M-0.01M
Change in Cash
-129.48M-30.07M-44.50M-44.66M59.16M-41.50M-46.73M-28.24M45.60M-50.50M6.75M48.01M-58.41M17.61M-17.05M-2.71M-17.38M28.80M3.30M0.12M
Free Cash FlowFCF
-42.56M-40.59M-53.64M-48.94M-37.03M-47.83M-52.99M-38.25M-34.49M-33.42M-52.30M116.35M-32.03M-35.48M-39.75M-47.11M-36.17M-48.31M-38.72M-39.42M
Net Cash FlowNCF
-129.88M-29.70M-44.34M-44.12M59.63M-42.14M-46.80M-28.22M45.74M-50.69M6.82M48.02M-58.51M17.73M-17.16M-2.84M-17.28M28.80M3.40M0.13M